Hillsdale Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.91M | Buy |
262,064
+69,900
| +36% | +$1.31M | 0.18% | 172 |
|
|
2025
Q1 | $3.46M | Buy |
192,164
+22,064
| +13% | +$397K | 0.18% | 155 |
|
|
2024
Q4 | $2.86M | Buy |
170,100
+151,500
| +815% | +$2.55M | 0.14% | 187 |
|
|
2024
Q3 | $301K | Buy |
+18,600
| New | +$301K | 0.02% | 366 |
|
|
2016
Q4 | – | Sell |
-2,540
| Closed | -$93K | – | 536 |
|
|
2016
Q3 | $93K | Buy |
+2,540
| New | +$93K | 0.02% | 307 |
|
|
2015
Q2 | – | Sell |
-1,180
| Closed | -$42K | – | 555 |
|
|
2015
Q1 | $42K | Buy |
+1,180
| New | +$42K | 0.01% | 445 |
|